IIM
APGE icon

INTECH Investment Management’s Apogee Therapeutics APGE Stock Holding History

INTECH Investment Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
8,884
-3,326
-27% -$300K 0.01% 956
2026
Q1 		$1.03M Sell
12,210
-1,491
-11% -$108K 0.01% 1009
2025
Q4 		$1.03M Hold
13,701
– – 0.01% 1120
2025
Q3 		$544K Sell
13,701
-2,369
-15% -$90.5K ﹤0.01% 1530
2025
Q2 		$698K Sell
16,070
-2,347
-13% -$89.3K 0.01% 1417
2025
Q1 		$688K Buy
18,417
+1,483
+9% +$57.3K 0.01% 1437
2024
Q4 		$767K Buy
16,934
+11,834
+232% +$604K 0.01% 1309
2024
Q3 		$300K Buy
+5,100
New +$244K ﹤0.01% 1525

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

INTECH Investment Management's APGE Position: Q2 2026 in Review

INTECH Investment Management reduced its Apogee Therapeutics (APGE) stake by 27% in Q2 2026, selling an estimated $300K and leaving 8,884 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #956.

INTECH Investment Management first reported a position in APGE in Q3 2024 and has held it in 8 quarters since. 288 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • INTECH Investment Management held 8,884 shares of Apogee Therapeutics worth $1.18M as of Q2 2026.
  • INTECH Investment Management sold 3,326 Apogee Therapeutics shares in Q2 2026, an estimated $300K.
  • Apogee Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #956 holding.
  • INTECH Investment Management first reported a position in Apogee Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 288 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.